Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$3.66 - $5.34 $92,737 - $135,304
25,338 Added 252.9%
35,357 $142,000
Q1 2024

Apr 25, 2024

BUY
$4.19 - $5.59 $29,426 - $39,258
7,023 Added 234.41%
10,019 $49,000
Q4 2023

Feb 02, 2024

BUY
$3.18 - $4.9 $9,527 - $14,680
2,996 New
2,996 $14,000
Q1 2020

Apr 29, 2020

SELL
$1.91 - $4.08 $20,253 - $43,264
-10,604 Closed
0 $0
Q4 2019

Feb 05, 2020

SELL
$0.71 - $4.91 $7,298 - $50,474
-10,280 Reduced 49.22%
10,604 $47,000
Q3 2019

Oct 15, 2019

BUY
$2.16 - $3.2 $45,109 - $66,828
20,884 New
20,884 $55,000
Q2 2019

Jul 26, 2019

SELL
$2.37 - $11.7 $104,066 - $513,746
-43,910 Closed
0 $0
Q1 2019

Apr 18, 2019

BUY
$6.71 - $8.6 $261,106 - $334,651
38,913 Added 778.73%
43,910 $0
Q4 2018

Jan 16, 2019

BUY
$6.27 - $10.92 $22,314 - $38,864
3,559 Added 247.5%
4,997 $37,000
Q3 2018

Oct 23, 2018

SELL
$10.49 - $12.87 $60,747 - $74,530
-5,791 Reduced 80.11%
1,438 $16,000
Q2 2018

Jul 30, 2018

BUY
$8.55 - $13.76 $58,319 - $93,856
6,821 Added 1671.81%
7,229 $81,000
Q1 2018

Apr 26, 2018

BUY
$8.99 - $14.95 $3,667 - $6,099
408 New
408 $3,000

Others Institutions Holding SVRA

About Savara Inc


  • Ticker SVRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,043,000
  • Market Cap $357M
  • Description
  • Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
More about SVRA
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.